Atrial septal defect closure

Andres F Vasquez1, John M Lasala

  • 1Division of Cardiology, Washington University School of Medicine, St Louis, MO 63110, USA.

Cardiology Clinics
|August 13, 2013
PubMed

Insights

Atrial septal defects (ASDs) are common congenital heart conditions. Percutaneous closure effectively halts right heart chamber volume overload in patients with ASDs.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Adult Congenital Heart Disease

Background:

  • Congenital heart disease (CHD) represents a significant cause of US hospital admissions.
  • Atrial septal defects (ASDs) are a prevalent form of CHD, particularly ostium secundum ASDs in adults.
  • Right cardiac chamber volume overload is a progressive complication of untreated ASDs.

Purpose of the Study:

  • To review the current understanding and management of percutaneous closure for atrial septal defects.
  • To highlight the importance of ASD closure in preventing cardiac complications.
  • To provide an overview of percutaneous techniques for ASD treatment.

Main Methods:

  • Literature review focusing on percutaneous closure of atrial septal defects.
  • Analysis of data regarding the prevalence and impact of ASDs.
  • Synthesis of information on the efficacy of interventional closure methods.

Main Results:

  • Atrial septal defects constitute a substantial portion of adult congenital heart conditions.
  • Percutaneous closure is an established method for treating ASDs.
  • Timely ASD closure mitigates the adverse effects of right heart volume overload.

Conclusions:

  • Percutaneous closure is a key therapeutic strategy for atrial septal defects.
  • Effective management of ASDs is crucial for improving long-term cardiac health.
  • This review emphasizes the role of minimally invasive techniques in treating congenital heart disease.